169 related articles for article (PubMed ID: 37147361)
1. The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma.
Nunes-Xavier CE; Emaldi M; Mingo J; Øyjord T; Mælandsmo GM; Fodstad Ø; Errarte P; Larrinaga G; Llarena R; López JI; Pulido R
Sci Rep; 2023 May; 13(1):7339. PubMed ID: 37147361
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer.
Nunes-Xavier CE; Mingo J; Emaldi M; Flem-Karlsen K; Mælandsmo GM; Fodstad Ø; Llarena R; López JI; Pulido R
Front Oncol; 2022; 12():873516. PubMed ID: 35692804
[TBL] [Abstract][Full Text] [Related]
3. Diversity of the pyruvate dehydrogenase kinase gene family in humans.
Gudi R; Bowker-Kinley MM; Kedishvili NY; Zhao Y; Popov KM
J Biol Chem; 1995 Dec; 270(48):28989-94. PubMed ID: 7499431
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
5. Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).
Baumunk D; Reichelt U; Hildebrandt J; Krause H; Ebbing J; Cash H; Miller K; Schostak M; Weikert S
World J Urol; 2013 Oct; 31(5):1191-6. PubMed ID: 22544372
[TBL] [Abstract][Full Text] [Related]
6. Marked differences between two isoforms of human pyruvate dehydrogenase kinase.
Baker JC; Yan X; Peng T; Kasten S; Roche TE
J Biol Chem; 2000 May; 275(21):15773-81. PubMed ID: 10748134
[TBL] [Abstract][Full Text] [Related]
7. Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.
Jane EP; Premkumar DR; Rajasundaram D; Thambireddy S; Reslink MC; Agnihotri S; Pollack IF
Mol Oncol; 2022 Jan; 16(1):219-249. PubMed ID: 34058053
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex.
Klyuyeva A; Tuganova A; Kedishvili N; Popov KM
J Biol Chem; 2019 Jan; 294(3):838-851. PubMed ID: 30482839
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis reveals PDK family as potential indicators related to prognosis and immune infiltration.
Tao S; Tao K; Cai X
Sci Rep; 2024 Mar; 14(1):5665. PubMed ID: 38453992
[TBL] [Abstract][Full Text] [Related]
10. HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.
Prigione A; Rohwer N; Hoffmann S; Mlody B; Drews K; Bukowiecki R; Blümlein K; Wanker EE; Ralser M; Cramer T; Adjaye J
Stem Cells; 2014 Feb; 32(2):364-76. PubMed ID: 24123565
[TBL] [Abstract][Full Text] [Related]
11. PDH activation during in vitro muscle contractions in PDH kinase 2 knockout mice: effect of PDH kinase 1 compensation.
Dunford EC; Herbst EA; Jeoung NH; Gittings W; Inglis JG; Vandenboom R; LeBlanc PJ; Harris RA; Peters SJ
Am J Physiol Regul Integr Comp Physiol; 2011 Jun; 300(6):R1487-93. PubMed ID: 21411764
[TBL] [Abstract][Full Text] [Related]
12. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer.
Lu CW; Lin SC; Chien CW; Lin SC; Lee CT; Lin BW; Lee JC; Tsai SJ
Am J Pathol; 2011 Sep; 179(3):1405-14. PubMed ID: 21763680
[TBL] [Abstract][Full Text] [Related]
14. Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells.
Abbot EL; McCormack JG; Reynet C; Hassall DG; Buchan KW; Yeaman SJ
FEBS J; 2005 Jun; 272(12):3004-14. PubMed ID: 15955060
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
16. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics.
Krencz I; Vetlényi E; Dankó T; Petővári G; Moldvai D; Sztankovics D; Raffay R; Mészáros K; Sebestyén E; Végső G; Pápay J; Sebestyén A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142502
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis.
Flora GD; Nayak MK; Ghatge M; Kumskova M; Patel RB; Chauhan AK
Blood Adv; 2023 Jun; 7(11):2347-2359. PubMed ID: 36971790
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α.
Škorja Milić N; Dolinar K; Miš K; Matkovič U; Bizjak M; Pavlin M; Podbregar M; Pirkmajer S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445316
[TBL] [Abstract][Full Text] [Related]
20. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
